Literature DB >> 22990733

Physiopathology of symptoms and signs in multiple sclerosis.

Maria José Sá1.   

Abstract

UNLABELLED: The physiopathology of symptoms and signs in multiple sclerosis (MS) is a less divulged topic albeit its importance in the patients' management.
OBJECTIVE: It was to summarize the main biophysical and biochemical mechanisms which produce the clinical manifestations in MS.
RESULTS: The mechanisms underpinning neurological deficits are described in the relapsing and in the progressive phases, stressing inflammatory and neurodegenerative components, especially demyelination, axonal damage and conduction impairment. Transient worsening based in Uhthoff's phenomenon, mechanisms producing positive symptoms, as paraesthesias and Lhermitte sign due to axonal hyperexcitability and ephaptic interactions, and development of cortical symptoms will also be addressed. The variety of processes leading to neural repair and functional recovery in the remitting phase is focused, as remyelination and adaptive changes due to neural plasticity.
CONCLUSION: The awareness of mechanisms producing symptoms in MS emphasises the role of symptomatic and rehabilitation therapies in the improvement of patients' well-being.

Entities:  

Mesh:

Year:  2012        PMID: 22990733     DOI: 10.1590/s0004-282x2012000900016

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

Review 1.  Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action.

Authors:  Seegehalli M Anil; Hadar Peeri; Hinanit Koltai
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 2.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

3.  Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.

Authors:  M Satue; E Garcia-Martin; I Fuertes; S Otin; R Alarcia; R Herrero; M P Bambo; L E Pablo; F J Fernandez
Journal:  Eye (Lond)       Date:  2013-02-22       Impact factor: 3.775

Review 4.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 5.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

Review 6.  Uhthoff`s phenomenon 125 years later - what do we know today?

Authors:  J A Opara; W Brola; A A Wylegala; E Wylegala
Journal:  J Med Life       Date:  2016 Jan-Mar

7.  Trichostatin A Promotes the Conversion of Astrocytes to Oligodendrocyte Progenitors in a Defined Culture Medium.

Authors:  Leila Zare; Hossein Baharvand; Mohammad Javan
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.